Eli Lilly (NYSE:LLY) shares gained after the U.S. Food and Drug Administration granted Breakthrough Therapy designation to its experimental antibody-drug conjugate, potentially accelerating the path to market for a treatment targeting hard-to-treat gynecologic cancers.
Fifth Third Bancorp (NASDAQ:FITB) reported fourth-quarter earnings that topped Wall Street expectations, driven by resilient lending activity and improved credit trends even as higher expenses weighed on efficiency.
Melbourne, Australia-based Telix Pharmaceuticals (NASDAQ:TLX) reported unaudited financial and operational highlights for the full year and fourth quarter ended December 31, 2025.
Boeing (NYSE:BA) secured a significant commitment from Ethiopian Airlines Group for 20 aircraft, as Africa's largest carrier moves to modernize its fleet and broaden its reach across four continents.
Novavax (NASDAQ:NVAX) shares rose in early trading after the company reached an agreement to license its vaccine-boosting technology to Pfizer (NYSE;PFE), providing a fresh source of capital for the Maryland-based biotech.
Fastenal (NASDAQ:FAST) met Wall Street’s fourth-quarter expectations for both profit and revenue, signaling resilience in the industrial supply sector despite a cooling macro environment.
Netflix (NYSE:WBD) and Warner Bros. Discovery (NYSE:WBD) amended their definitive merger agreement on Tuesday, pivoting to an all-cash transaction to provide shareholders with greater price protection and accelerate the closing timeline.
Forestar Group (NYSE:FOR) reported fiscal first-quarter results on Tuesday that aligned with analyst expectations, balancing a modest decline in bottom-line profit with a steady increase in top-line revenue.
3M (NYSE:MMM) delivered fourth-quarter results on Tuesday that underscored the industrial giant’s successful shift toward operational leaness, as adjusted operating margins reached 21.1%—a 140-basis-point improvement over the previous year.
KeyCorp (NYSE:KEY) reported record full-year results for 2025, capped by a fourth quarter that saw net income climb to $474 million, or $0.43 per diluted share.
McEwen Mining (NYSE:MUX) announced a significant expansion of the gold resource at its Grey Fox project in Ontario, marking a key milestone for the company’s broader Fox Complex.
Moderna (NASDAQ:MRNA) and Merck (NYSE:MRK) announced Tuesday that their individualized neoantigen therapy continues to show dramatic long-term benefits, providing the strongest evidence to date that mRNA technology can be harnessed to treat established cancer.
-1-640x358.jpg&w=3840&q=75)
